InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
T+90 hit rate
50%
T+90 mean return
-0.5%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Cadoret-Manier Onaiza, Director. Officer active across 2 companies, notably Ionis Pharmaceuticals INC. Cumulatively, 14 filings have been recorded. Split: 0 buy · 1 sell. Total volume traded: €99k. History available since 31 August 2021. The latest transaction was disclosed on 2 February 2024 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations14 total
26,455 sharesCommon StockSEC:0001799355-26-000006:0
▼
2,162 shares@ US$49.60280.0% of flowCommon StockSEC:0000874015-24-000194:0
4,140 shares0Common StockSEC:0000874015-24-000104:0
15,062 shares0Common StockSEC:0000874015-24-000081:0
12,755 shares0Common StockSEC:0001628280-23-022557:0
5,667 shares0Common StockSEC:0000874015-23-000131:0
4,140 shares0Common StockSEC:0000874015-23-000090:0
10,197 shares0Common StockSEC:0000874015-23-000063:0
91,240 shares0Common StockSEC:0001567619-22-013085:0
5,667 shares0Common StockSEC:0000874015-22-000099:0
6,057 shares0Common StockSEC:0000874015-22-000057:0
6,057 shares0Common StockSEC:0000874015-22-000057
●
431 shares@ US$33.7960.0001% mcap50.0% of flowCommon StockSEC:0000874015-21-000152:0
●
431 shares@ US$33.79610.0% of flowCommon StockSEC:0000874015-21-000152
14 of 14 declarations
About Cadoret-Manier Onaiza
Onaiza Cadoret-Manier is Chief Corp Dev and Cml Officer and a Director at IONIS PHARMACEUTICALS INC and ARDELYX, INC. She oversees corporate and commercial development for the companies. Her expertise is essential in guiding growth strategy.
